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ABSTRACT The Tar receptor is a transmembrane protein
that regulates bacterial chemotaxis in response to changes in
the level of aspartic acid in the medium. The extracellular
portion of the protein can bind aspartate, and the cytoplasmic
portion modulates CheA kinase activity. The receptor can
either activate or inhibit the kinase. The cytoplasmic portion of
the receptor can be modified by c.rboxymethylation of specific
glutamic acid residues. To test the effects of differential meth-
ylation on receptor function, we prepared membranes from
cells that have specifically modified forms of the receptor and
tested the relative ability of each of these forms to activate or
inhibit CheA kinase. Completely demethylated receptor was a
potent inhibitor and poor activator ofthe kinase, while the fully
modified receptor was an excellent activator but an inefficient
inhibitor. Partially modified receptor could act both as an
effective inhibitor and as an activator. Reversible modification
provides a mechanism that allows the cell to accumulate a
population of receptor molecules capable of generating a wide
range of signaling intensities.
Bacterial swimming and chemotaxis are driven by flagellar
filament rotation. The cell is capable ofchanging the direction
of flagellar rotation; counterclockwise rotation results in
smooth swimming, while switching to clockwise rotation
causes the organism to tumble and alter its swimming direc-
tion (for reviews, see refs. 1-3). Bacteria can modulate the
frequency of smooth versus tumbly swimming episodes in
response to a variety of chemical stimuli. A gradient of
increasing concentration of attractant or decreasing repellent
concentration results in increased smooth swimming periods
with a net migration of the organism to the more favorable
environment (4). Conversely, increasing concentrations of
repellents or decreasing attractant concentrations result in
increased frequencies of tumbling. Modulation of the fre-
quency of change in direction of flagellar rotation appears to
regulate bacterial chemotaxis.
In Escherichia coli and Salmonella typhimurium, a variety
of chemical stimuli are sensed by any one of four different
transmembrane receptors. These proteins are part of a signal
transducing system that the cell uses to compare the current
level of a specific ligand with the concentration experienced
in the recent past and to adjust swimming behavior appro-
priately. Signal transduction in bacterial chemotaxis involves
two highly integrated processes, which have been referred to
as excitation and adaptation. The excitation process reflects
the instantaneous changes in the state of specific transmem-
brane receptors. Ligand release from the periplasmic portion
of one of these receptors (e.g., the aspartate receptor Tar)
results in transmembrane signal transmission, which presum-
ably causes the signaling properties of the cytoplasmic do-
main of the receptor to change. The cytoplasmic portion of
the transmembrane receptor interacts with two soluble pro-
teins, CheA and CheW. The CheA protein kinase is activated
in this process and phosphorylates the CheY protein, which
acts as a "second messenger" to change the bias of flagellar
rotation and thus presumably induces a brief period of
tumbling (5, 6). Binding of ligand to receptor can also
"inhibit" CheA kinase activity and thus stabilize the direc-
tion of flagellar rotation, eliminating episodes of "tumbling"
and resulting in longer periods of "smooth" swimming (7).
The second process that can be distinguished experimen-
tally is adaptation. It is brought about by action of the CheR
and CheB proteins (8-10). CheR catalyzes the S-adenosyl-
methionine-dependent carboxymethylation of specific glu-
tamic acid residues on the cytoplasmic portion of the recep-
tor. This reaction is reversed by the CheB protein, which
catalyzes hydrolysis ofthese methylesters. The Tar chemore-
ceptor contains four glutamate residues, which are subject to
reversible modification. In the newly synthesized transmem-
brane protein, they are present as two glutamines and two
glutamates (Q295, E302, Q309, and E491 of Tar) (11, 12).
Deamidation of the glutamines to glutamates is catalyzed by
a second enzymatic activity of the CheB protein (11, 13).
Activation of the methylesterase activity of CheB results
from its phosphorylation by the CheA kinase (14-17). Bind-
ing of attractant ligands leads to increased steady-state levels
of methylation of the receptors, since the kinase is inhibited
and CheB activity is diminished. Continuous methylation of
the receptors is facilitated by CheR. Thus far, no specific
mechanism for regulation ofCheR methyltransferase activity
has been found.
Both CheR and CheB are necessary for sensing spatial
gradients by the chemoreceptors. Analysis of the swimming
behavior of several chemotaxis mutants showed that mutants
that lack CheR activity are smooth swimming (9, 18, 19).
Cells that are deficient in CheB activity show tumbly behav-
ior and cheRcheB double mutants are also tumbly (20-24).
However, experiments with tethered cells demonstrate that
even cheRcheB double mutants can respond by changing the
direction of flagellar rotation when exposed to large doses of
attractants (24-26). This indicates that even though the cells
lack the apparatus to generate an adaptation response, they
still have a functional excitation pathway.
A variety of elegant physiological studies have suggested
that methylation serves to alter the signaling properties ofthe
receptor. How does methylation ofthe receptor modulate the
excitation process? Methylation does not appear to dramat-
ically change the affinity of receptor for ligand (25, 27); thus,
we might expect it to affect the ability of the receptor to
interact with CheA kinase. In this study, we use the in vitro
reconstitution system to examine the role that receptor
methylation plays in its ability to activate and inhibit the
CheA kinase in order to ascertain the biochemical basis for
modulation of the excitation response.
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MATERIALS AND METHODS
Production of Differentially Modifiled Receptors. Plasmid
pNT201, which carries the wild-type tar gene under control
of a tac promoter, the 8-lactamase gene, and a ColEl origin
of replication, has been described (28). Compatible plasmids
containing the piSA origin of replication, the chlorampheni-
col-resistance gene, and either the cheR or cheB gene with a
tac promoter were constructed as follows. Plasmid pKB23
(cheR+) was made by insertion of the Pvu II/HindIII frag-
ment containing the cheR gene (with a tac promoter) from
plasmid p43:cheR into the vector pACYC184 cut with EcoRV
and HindIII. Likewise, plasmid pKB24 (cheB+) was con-
structed by insertion of the Pvu II/Sal I fragment from
p43:cheB (containing the cheB gene fused to a tac promoter)
into pACYC184 cut with EcoRV and Sal I. Plasmids
p43:cheR and p43:chej3 were obtained from R. Stewart
(McGill University, Montreal, Quebec, Canada). Strain
HCB721 [A(tsr)7021 trg: :TnJOA(cheA-che I: :Xho(TnS)]
(29), in which all four chemoreceptors and the cytoplasmic
chemotaxis proteins are deleted, was used as the recipient for
these studies. The Tar chemoreceptor contains four potential
sites of methylation, which are synthesized as Q295, E302,
Q309, and E491 (11, 12); hence, the notation QEQE. A
cheR-cheB- strain containing unmodified Tar receptors
(QEQE) was made by transformation of HCB721 with both
pNT201 and pACYC184. Transformation of HCB721 with
pNT201 and either pKB23 or pKB24 yielded a strain con-
taining the Tar receptor in either a cheR+cheB- [containing
QEmQEm receptors (Em is methylglutamate)] or a
cheR-cheB+ background (containing EEEE receptors), re-
spectively. HCB721 transformed with both pUC9 (no recep-
tor) and pACYC184 was the control strain. Cultures were
grown under appropriate antibiotic selection and isopropyl
,8-D-thiogalactopyranoside was used to induce expression of
proteins as described (7). Aspartate (final concentration, 10
mM) was added to cultures of strain HCB721 transformed
with pNT201 and pKB23 to drive methylation ofthe receptor.
Extraction of cells and membrane isolations was as described
(7). Aliquots containing 2.5 ,ug of membrane protein were
subjected to SDS/PAGE analysis (30) using low-crosslinking
gels (31), after which the gel was Coomassie stained and
photographed. Quantitation of Tar in the membrane prepa-
rations was estimated by densitometry as described (7).
Construction of an EEEE Tar mutant was accomplished as
follows. Site-directed mutagenesis was carried out in plasmid
pKB28, which contains the C-terminal fragment of Tar
(K.A.B., unpublished results), using two oligonucleotides in
tandem. Oligonucleotides spanning residues 295 and 309
were made that encoded a change from CAG to GAG. The
resulting Kpn I/Sst II fragment containing the desired double
mutation was then subcloned back into the parent expression
vector pNT201 cut at these sites to yield pNT295E-309E.
Transformation of HCB721 with pNT295E-309E and pKB23
yielded the fully methylated receptor EmEmEmEm.
Activation of CheY Phosphate Formation by the Four Mem-
brane Preparations. Reconstituted phosphorylation assays
were performed at room temperature as described (7). In
these reactions, we believe that the first step of the mecha-
nism is the activation of CheA autophosphorylation by the
receptor and CheW. Phosphate is then transferred from
CheA to the CheY protein. Reaction mixtures contained 50
mM Tris HCl (pH 7.5), 50 mM KCl, 5 mM MgCl2, 0.1 mM
['y-32P]ATP (9250 cpm/pmol), 20 ,g of membrane protein
(corresponding to -80 pmol of Tar receptor; an exception is
the control preparation, which contains no receptor), 2 pmol
of CheA, 40 pmol of CheW, and 300 pmol of CheY in a total
vol of 20 gl. The reactions were quenched with 5 ul of
Laemmli sample buffer (30) containing 25 mM EDTA and
electrophoresis was on SDS/12.5% polyacrylamide gels (30).
Radioactive phosphate present in the CheY protein was
quantitated by excising the band from the dried gel and
assaying in scintillation fluid. Rates were determined be-
tween 5 and 10 sec of reaction.
Determination of IC5s. The IC50 is given as the concentra-
tion of L-aspartate (synthetic) that inhibits the rate of CheY
phosphate formation by 50%o of the maximum for that recep-
tor in the absence of L-aspartate. Reactions were performed
as described above. Reciprocal plots of1/% inhibition versus
1/[L-aspartate] were used to determine the IC50 value (R =
0.90-0.99). The IC50 for the EmEmEmEm form is reported
as >50 mM, as its activity could not be inhibited even in the
presence of 50 mM aspartate.
Kd Determination. The Kd for L-aspartate binding was
determined by a variation of the method of Clarke and
Koshland (32): 40 gg ofmembrane protein (=160 pmol ofTar)
in 100 Aul of 50 mM Tris-HC1, pH 7.5/50 mM KCl was
incubated (20 min at 220C) with various concentrations (0.25-
700 ,uM) of L-[U-14C]aspartic acid (New England Nuclear;
200 mCi/mmol; 1 Ci = 37 GBq). Membranes were pelleted by
centrifugation in a Beckman Airfuge (15 min at 100,000 x g).
The concentration of free aspartate was determined by as-
saying the supernatant and the concentration ofbound ligand
by counting the pellet after solubilization in 4% SDS. Cor-
rections were made for nonspecific binding of radioactivity
by running parallel reactions with 20 mM sodium L-aspartate.
Control reactions with membranes containing no receptor (40
,ug of membrane protein) showed that there was no specific
binding of L-aspartate. In addition, thin-layer chromatogra-
phy analysis of the reaction mixture (1-butanol/acetic acid/
water; 4:1:1) indicated that there was no decomposition ofthe
aspartate by the membranes at 22°C over the time course of
the experiment. Binding constants were determined from
Scatchard analysis of the data (see Fig. 3) (33). There was no
evidence for multiple binding sites or cooperativity (n = 1; R
= 0.9) in the concentration range of aspartate tested. Kd
values in the millimolar range would not have been detected.
Duplicate measurements were made for each concentration,
and Kd values are averages of at least three separate exper-
iments. Stoichiometry of labeling indicates 0.5 mol of aspar-
tate bound per mol of Tar monomer. As Tar has been
reported to be a dimer (34), this may indicate that only one
site on the dimer is occupied. Alternatively, only 50%o of the
total sites may be available for ligand binding due to seques-
tration in membranes. We cannot distinguish these possibil-
ities at this time. Absolute values for IC50 and Kd may be
different as they were measured under different conditions;
reaction mixtures for determining Kd values do not contain
CheA, CheW, CheY, or MgATP.
Assay of Receptor-Mediated Inhibition of the CheA Kinase.
Reaction mixtures contained 2 pmol of CheA; 40 pmol of
CheW; 450 pmol of CheY; tumble mutant Tar (pNT201-N101)
(28) (3.3 ,ug of membrane protein or =14 pmol of receptor);
either control membranes, EEEE, QEQE, or QEmQEm Tar
receptor-containing membranes (20 pg of membrane protein
or 84 pmol of receptor); 0.1 mM ATP (7670 cpm/pmol); and
either 1 mM L-aspartate or water (control). Assay time was
5 sec. Reaction mixtures were quenched and the amount of
CheY phosphate was quantitated as described above.
RESULTS
Covalent Modification Alters the Signaling Properties of the
Receptor. To test the ability of differentially modified recep-
tors to activate the phosphoryl transfer system, membranes
from strains containing EEEE, QEQE, or QEmQEm Tar
chemoreceptors (see Materials and Methods) were prepared.
The various methylated forms of Tar can be separated by
SDS/PAGE in low-crosslinking gels (Fig. 1A). The expres-
sion of tar from pNT201 in cells overexpressing CheR, CheB,
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FIG. 1. Analysis of differentially modified Tar receptor-con-
taining membranes. (A) The EEEE, QEQE, and QEmQEm forms of
Tar can be distinguished by migration through a 10% low-
crosslinking SDS/polyacrylamide gel. (B) Comparison of each of the
modified Tar receptors to stimulate the level of CheY phosphate in
a coupled in vitro assay system. *, It is not possible to determine a
rate of CheY phosphate formation for the control preparation since,
under these conditions, phosphorylation of the CheA kinase is the
rate-limiting step. To allow comparison of all four preparations, we
report the following amounts ofCheY phosphate (cpm) present after
5 sec of reaction: control, 700; EEEE, 800; QEQE, 16,000;
QEmQEm, 32,000.
or a control plasmid yielded pure populations of the differ-
entially modified forms.
The various washed membrane preparations were tested
for their ability to activate CheY phosphorylation in the
reconstituted system containing CheW, CheY, ATP, and
limiting amounts of the CheA kinase (7). The rate of CheY
phosphate formation serves as a measure of the relative
ability of the different receptor preparations to stimulate the
kinase. There was a 40-fold difference in the activating
abilities of the three receptors in the absence of ligand (Fig.
1B). The QEmQEm receptor gave the greatest amount of
stimulation ofthe kinase, the QEQE variant was intermediate
(50% QEmQEm), and the EEEE receptor produced levels of
CheY phosphatejust above background (2.5% ofQEmQEm).
These results are consistent with phenotypes observed for
chemotaxis mutants where receptor modification is affected.
It has been suggested, on the basis of behavioral studies and
biochemical studies, that glutamine residues mimic the prop-
erties of methylglutamates (23, 25). The cheR mutant is
smooth swimming, presumably because it contains nonacti-
vating EEEE receptors, while both the cheB mutant and the
cheRcheB double-mutant cell exhibit tumbly behavior due to
the presence of activating QEmQEm and QEQE receptors,
FIG. 2. Aspartate affects the signaling activity of each modified
Tar differently. Activity is relative to the maximal amount of
activation observed for each receptor in the absence of ligand.
respectively (10, 22-24). Therefore, increasing activation of
phosphorylation correlates with substitution of glutamine or
methylglutamate for glutamate residues in the chemorecep-
tor.
Sensitivity of Differentially Modified Tar Receptors to Li-
gand. We next tested the ability of aspartate to modulate the
activating properties of different receptors. The products of
the cheR and cheB genes are essential for adaptation to
occur. However, cells lacking one or both of these genes still
retain the ability to modulate the direction offlagellar rotation
in response to large doses of ligand. The phosphoryl transfer
reaction stimulated by each of the receptor preparations was
tested with L-aspartate. All three receptors examined in the
in vitro assay system were sensitive to added aspartate (Fig.
2). However, the concentration required to inhibit CheY
phosphate formation by 50%, the IC50, was 170-fold greater
for the QEmQEm receptor than for either the EEEE or the
QEQE receptor (Table 1). One explanation of these results
might be that the affinity of the receptor for aspartate
decreases as methylation levels increase. However, previous
results suggested that there was only a relatively small
change in affinity as a function of modification (25). We
repeated these measurements with our preparations. Fig. 3
shows the Scatchard analysis of the binding data. The Kd of
L-aspartate for the receptors (Fig. 3) showed an E7-fold
difference in ligand affinity between the EEEE form and the
QEmQEm form (Table 1). These results indicate that the
presence of methylglutamates results in a receptor less sen-
sitive to inhibition of the kinase in response to attractant
ligands and that this effect may in part be due to a decreased
binding affinity for the ligand. To further test this conclusion,
we prepared a mutant Tar receptor in which glutamines 295
and 309 were replaced by glutamate. Expression of this
mutant in the cheB background yielded the totally methylated
receptor (EmEmEmEm). This form of the receptor activated
the kinase slightly better than the QEmQEm form (data not
shown) and it also bound aspartate with a Kd of 20 ,tM (Table
1). Interestingly, its activity was not affected by the presence
Table 1. Summary of aspartate effects on differentially
modified receptors
Receptor type Kd, ,uM IC50, /AM
EEEE 3.5 + 0.5 0.65 ± 0.50
QEQE 7.5 ± 1.7 0.70 + 0.17
QEmQEm 30.0 + 8.2 120 ± 16
EmEmEmEm 18.4 ± 2.2 >50 x 103
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FIG. 3. Scatchard analysis of L-[14C]aspartate binding to the
EEEE, QEQE, and QEmQEm forms of Tar-containing membranes.
No evidence exists for cooperativity, and only one type of binding
site appears to be present.
of aspartate even up to concentrations of 50 mM, essentially
resulting in a receptor whose activating ability is uncoupled
from the binding of aspartate. Thus, our results suggest that
increased modification of the receptor does result in a de-
crease in ligand binding; however, this 7-fold change is
relatively small compared to the differences in the activating
abilities of the differentially methylated receptors or com-
pared to the differences in their sensitivity to aspartate.
Receptor-Mediated Inhibition of the CheA Kinase. Exami-
nation of the relative sensitivity of the receptors to aspartate
indicates that for the QEQE receptor only 15% of the given
receptors need to be occupied to inhibit the cheA kinase
activity by 50% compared to occupancy of 85% of the sites
in the case of the QEmQEm receptor. One way to explain
these marked differences ascribes them to changes in the
nature of the signaling processes mediated by the different
receptors. We have previously shown that the QEQE recep-
tor is capable of both stimulatory and inhibitory signaling (7).
It is possible that the modification state of the receptor could
also affect the relative ability of the receptor to inhibit and to
stimulate the CheA kinase. To examine the inhibitory activ-
ity, we tested the ability of the modified receptors to influ-
ence the activation of CheY phosphate formation catalyzed
by a tumble mutant Tar receptor. Work in our laboratory has
shown that the tumble mutant of Tar constitutively activates
the kinase even in the presence of aspartate (7). In this assay,
the modified receptor of interest was mixed with the tumble
mutant in the presence or absence of aspartate and the
production of CheY phosphate was monitored (Fig. 4). TheQEmQEm receptor showed little or no inhibition of CheY
phosphate formation by the tumble receptor under any con-
ditions. The QEQE receptor challenged the phosphorylation
activity of the tumble receptor only in the presence of
aspartate. In contrast, the EEEE receptor showed a striking
inhibition of phosphorylation (50%) even in the absence of
E
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FIG. 4. Inhibition of a tumble mutant Tar receptor by each of the
modified forms in the presence or absence of aspartate.
ligand. Thus, the differentially modified forms ofthe receptor
have very different abilities with respect to activation and
inhibition of CheA kinase (Fig. 4). The EEEE receptor,
which is poorest in its ability to activate, is the most potent
inhibitor even in the absence of ligand. The half-modified
receptor (QEQE) is an effective activator in the absence of
aspartate and an effective inhibitor in its presence. While the
fully modified form (QEmQEm) shows little if any ability to
inhibit even when saturated with aspartate, it is nonetheless
a very powerful activator of the CheA kinase.
DISCUSSION
Our results indicate that replacement of glutamate with
glutamine or methylglutamate in the cytoplasmic domain of
Tar increases the ability of the receptor to activate the CheA
kinase, resulting in increased formation of CheY phosphate
(Fig. 1B). Thus, methylation alters the activating signaling
properties of the receptor. Various lines of evidence impli-
cate CheY phosphate as the tumble regulator in the chemo-
taxis pathway, this is consistent with the observed phenotype
of strains containing each of these modified receptors. Bac-
teria that have the EEEE form of the receptor exhibit a
smooth swimming phenotype presumably because even in
the absence of ligand the receptor does not lead to the
production of significant levels of CheY phosphate. The
QEQE form is able to activate the kinase at an intermediate
level and these bacteria show a tumble bias. The receptor
most capable of generating tumbles, QEmQEm, is also the
most effective stimulator of CheY phosphate production.
The sensitivity of each of these receptors to ligand is a
function of the modification state of the protein. Receptors
with high levels of modification are less sensitive to aspar-
tate. This change can be accounted for only in part by the
7-fold difference found in the dissociation constant for the
ligand aspartate. The 200-fold difference in sensitivity be-
tween EEEE and QEmQEm (and >50 x 103-fold for
EmEmEmEm) apparently results from alterations in the
structure of the signaling domain due to covalent modifica-
tion.
The ability of the receptors to generate an inhibitory
response is also dependent on the modification state of the
receptor. Thus, unmodified receptor (EEEE) is a potent
inhibitor, while inhibition could not be detected with the fully
modified receptor (QEmQEm). The partially modified recep-
tor (QEQE) shows the greatest range of responsiveness and
thus the highest gain-i.e., the greatest difference in kinase
activation as a function of receptor occupancy. Thus, the
binding of ligand both eliminates the activation function of
the receptor and stimulates inhibition resulting in a "push-
pull" mechanism. This could account for the observation that
in vivo, occupancy of a small fraction of receptors can result
in an observable effect on bacterial swimming behavior (35).
These results suggest that the inhibitory response plays an
important role in regulating chemotaxis. The physical mech-
anisms involved in both the activation and inhibition of the
kinase by receptor remain obscure. The picture that emerges
is that receptors can exist as a heterogeneous mixture of
multiply methylated molecules where there is little (-7-fold)
difference in ligand affinity as a function of methylation but
the different modified forms of the receptor show a marked
range in their ability to activate or inhibit the kinase. The
"gain" observed in response to incremental changes in ligand
concentration could be mediated by changes in the popula-
tion of differentially methylated forms of receptor molecules.
Our in vitro assays correlate well with behavioral analyses
of a variety of chemotaxis mutants in several laboratories.
Recently, workers have shown that increasing substitution of
glutamate with glutamine or alanine results in cells with an
increased tumble swimming bias (25, 26). These substitutions
-Aspartate ,AsuLCrtatC
Hc mUM - -
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also resulted in receptors less sensitive to ligand asjudged by
the ability of swimming behavior to be reversed by changes
in ligand concentration. Dunten and Koshland (25) found
only a 2-fold difference in affinity ofreceptor for ligand when
they compared EEEE to QQQQ forms. We can reconcile the
apparent differences in affinities observed in our experiments
if it is assumed that glutamine is not as effective as a
methylglutamate residue in decreasing the binding affinity of
the receptor for aspartate.
Analyses of our binding data (Fig. 3) suggest that a dimer
of the Tar receptor binds one molecule of aspartate. These
results agree with recent crystallographic studies (36). The
crystal structure of the Tar periplasmic region shows a single
molecule of aspartate bound per dimer. However, the differ-
ences between the ligand occupied and the unoccupied
periplasmic domain of the receptor have not as yet given us
a clear picture of the structural change that is transmitted
across the membrane. Our results suggest that differences in
the level of methylation of the cytoplasmic region of the
receptor can modulate this signal and transduce it into
different extents of activation or inhibition of the CheA
kinase.
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